ČCHENG-TU, Čína, 12. června 2023 /PRNewswire/ – Dne 8. června 2023 byla příslušnými úřady v Číně schválena trivalentní vakcína Coviccine® XBB.1.5-Recombinant COVID-19 Trivalent (XBB.1.5+BA.5+Delta) Protein Vaccine (Sf9 cell), vyvinutá společností WestVac Biopharma / West China Medical…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.